Practicing Alternative Techniques to Heal From Depression: The PATH-D Study

This study is currently recruiting participants.
Verified June 2012 by University of California, San Francisco
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Stuart Eisendrath, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01021254
First received: November 24, 2009
Last updated: June 12, 2012
Last verified: June 2012

November 24, 2009
June 12, 2012
September 2009
August 2012   (final data collection date for primary outcome measure)
Hamilton Depression Rating Scale (HAMD-17) [ Time Frame: Baseline, 4,8,24,36,52 week ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01021254 on ClinicalTrials.gov Archive Site
  • Quick Inventory of Depressive Symptomatology (QIDS-SR16) [ Time Frame: Baseline, weeks 1-8, 24, 36, 52 week ] [ Designated as safety issue: No ]
  • Short Form Health Survey- 12 (SF-12) [ Time Frame: Baseline, 8, 24, 36, 52 week ] [ Designated as safety issue: No ]
  • Clinical Global Improvement Scale (CGI) [ Time Frame: Baseline, 8, 24, 36, 52 weeks ] [ Designated as safety issue: No ]
  • Work and Social Activity Scale (WSAS) [ Time Frame: Baseline, 8, 24,36,52 weeks ] [ Designated as safety issue: No ]
  • Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (QLESQ-SF) [ Time Frame: Baseline, 8, 24, 36, 52 weeks ] [ Designated as safety issue: No ]
Same as current
 
 
 
Practicing Alternative Techniques to Heal From Depression: The PATH-D Study
Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression

This study is a randomized, controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus the Health-Enhancement Program (HEP) for patients with treatment-resistant depression. Both arms of the study will continue to receive the standard medication management treatment as usual (TAU) throughout the study.

Mindfulness-Based Cognitive Therapy (MBCT) is an 8-week group intervention that uses mindfulness meditation as its core therapeutic ingredient. It teaches people to have a different relationship to depressive thoughts and feelings. The Health-Enhancement Program (HEP) was developed by researches at the University of Wisconsin, Madison. It has been shown to decrease global stress levels and to increase perceived health which literature has indicated to be contributors to depression. 124 patients with major depressive disorder (MDD)and who have failed to remit from two or more adequate antidepressant trials will be identified and randomized to one of two treatment arms: MBCT+TAU or HEP +TAU. All patients enrolled in the study will undergo research assessments pre and post treatment (baseline and 8-week) and follow-up assessments at months 3,6,9, and 12.

Interventional
 
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Major Depressive Disorder
  • Behavioral: Mindfulness-Based Cognitive Therapy (MBCT)
    MBCT is a group treatment that integrates mindfulness meditation training with some elements of cognitive behavioral therapy (CBT). The program teaches patients how to disengage from habitual, dysfunctional cognitive routines, in particular depression-related ruminative thought patterns.
    Other Name: MBCT
  • Behavioral: Health-Enhancement Program (HEP)
    HEP was developed at the University of Wisconsin, Madison and is modeled after traditional activity and nutrition programs used in weight management-cardiac rehab and diabetes prevention programs. HEP is designed to increase overall health and well-being by focusing on four health domains that impact health and are interventions regularly practiced at integrative medicine. These include: Music Therapy, Nutrition, Physical Activity and Functional Movement
    Other Name: HEP
  • Experimental: 1
    Mindfulness-Based Cognitive Therapy (MBCT) + medication management treatment as usual (TAU)
    Intervention: Behavioral: Mindfulness-Based Cognitive Therapy (MBCT)
  • Active Comparator: 2
    The Health-Enhancement Program (HEP) + medication management treatment as usual (TAU)
    Intervention: Behavioral: Health-Enhancement Program (HEP)

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
124
February 2013
August 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • DSM-IV Diagnosis of Major Depressive Disorder (MDD)
  • Adequate trail of 2 or more antidepressants for a minimum of 6 weeks (one of which is at UCSF)
  • Hamilton Depression Rating Scale score of >= 14
  • English Speaking
  • Not currently in individual or group psychotherapy

Exclusion Criteria:

  • Bipolar Disorder
  • Obsessive Compulsive Disorder
  • Schizophrenia
  • Schizoaffective Disorder
  • Antisocial Personality Disorder
  • Pervasive Developmental Delay
  • Major Depression with Psychotic Features
Both
18 Years and older
No
Contact: Erin P Gillung, MA (415) 476-7866 egillung@lppi.ucsf.edu
Contact: Stuart J Eisendrath, MD (415) ext 476-7868 StuartE@lppi.ucsf.edu
United States
 
NCT01021254
RO1 AT004572-O1A1
Yes
Stuart Eisendrath, University of California, San Francisco
University of California, San Francisco
National Center for Complementary and Alternative Medicine (NCCAM)
Principal Investigator: Stuart J Eisendrath, MD University of California, San Francisco
University of California, San Francisco
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP